Repetitive TMS (rTMS) segment to Register Highest CAGR in Transcranial Magnetic Stimulator (TMS) Market During 2021–2028

According to our latest study on “US Transcranial Magnetic Stimulator (TMS) Market Forecast to 2028 – COVID-19 Impact and US Analysis – by Type, Age Group, and Application,” the market was valued at US$ 309.53 million in 2020 and is projected to reach US$ 631.29 million by 2028; it is expected to grow at a CAGR of 9.4% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.

Based on type, the transcranial magnetic stimulator (TMS) market is bifurcated into single or paired pulse TMS and repetitive TMS (rTMS). In 2020, the single or paired pulse TMS segment held a larger share of the market. The market growth for this segment is attributed to the growing applications of the transcranial magnetic stimulator technique in the diagnosis and treatment of neurological disorders. However, the market for the repetitive TMS (rTMS) segment is expected to grow at a faster rate during the coming years.

The growth of the transcranial magnetic stimulator (TMS) market is primarily attributed to the factors such as the increasing geriatric population and neurological disorders associated with age, and presence of well-established healthcare facilities. However, the high cost of diagnostic and treatment hinders the growth of the market.

BrainsWay Ltd; Nexstim; Magstim; Neuronetics; TMS Neuro Solutions; MagVenture, Inc.; eNeura Inc.; Neurosoft; and MAG & More GmbH are the leading companies operating in the US transcranial magnetic stimulator (TMS) market.

The report segments US Transcranial Magnetic Stimulator (TMS) market as Follows:

By Type

• Single or Paired Pulse TMS
• Repetitive TMS (rTMS)

By Age Group

• Adults
• Children

By Application

• Research
• Diagnostic
• Therapeutic

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com